Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

Abstract Cardiovascular disease is the leading cause of death worldwide. New therapeutic strategies are aimed to modulate the athero-inflammatory process that partially orchestrates underlying vascular damage. Peripheral blood circulating cells include different immune cells with a central role in t...

Full description

Bibliographic Details
Main Authors:	Ernesto Martín-Núñez, Atteneri Pérez-Castro, Víctor G. Tagua, Carolina Hernández-Carballo, Carla Ferri, Nayra Pérez-Delgado, Sergio Rodríguez-Ramos, Purificación Cerro-López, Ángel López-Castillo, Alejandro Delgado-Molinos, Victoria Castro López-Tarruella, Miguel A. Arévalo-Gómez, Ainhoa González-Luis, Alberto Martín-Olivera, Carmen Chaxiraxi Morales-Estévez, Carmen Mora-Fernández, Javier Donate-Correa, Juan F. Navarro-González
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-12548-z

Similar Items

Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study
by: Javier Donate-Correa, et al.
Published: (2023-05-01)

Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
by: Javier Donate-Correa, et al.
Published: (2021-08-01)

Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
by: Julia Martín-Vírgala, et al.
Published: (2023-03-01)

Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study
by: Javier Donate-Correa, et al.
Published: (2023-08-01)

Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease
by: Javier Donate-Correa, et al.
Published: (2023-01-01)

Inflammatory Mediators in Atherosclerotic Vascular Remodeling
by: Bryce R. Evans, et al.
Published: (2022-05-01)

Arterial klotho expression and FGF23 effects on vascular calcification and function.
by: Karolina Lindberg, et al.
Published: (2013-01-01)

Shedding of Klotho: Functional Implications in Chronic Kidney Disease and Associated Vascular Disease
by: Valeria Saar-Kovrov, et al.
Published: (2021-01-01)

Therapeutic Interference With Vascular Calcification—Lessons From Klotho-Hypomorphic Mice and Beyond
by: Florian Lang, et al.
Published: (2018-05-01)

Effects of anacetrapib in patients with atherosclerotic vascular disease
by: Bowman, L, et al.
Published: (2017)

Atherosclerotic vascular disorders in HIV infected patients
by: John Palios, et al.
Published: (2011-07-01)

Metabolic Syndrome in Patients with Atherosclerotic Vascular Disease
by: Sadaf Zaman
Published: (2016-06-01)

Digital interventions in the treatment of cardiovascular risk factors and atherosclerotic vascular disease
by: Martin Steinmetz, et al.
Published: (2020-02-01)

Extracellular water/total body water ratio as predictor of mortality in hemodialysis patients
by: Rosa Pérez-Morales, et al.
Published: (2021-01-01)

Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
by: Javier Donate-Correa, et al.
Published: (2021-06-01)

Inducing Energetic Switching Using Klotho Improves Vascular Smooth Muscle Cell Phenotype
by: Craig K. Docherty, et al.
Published: (2021-12-01)

Blood microflora of patients with atherosclerotic vascular lesions and microflora of atherosclerotic plaques of carotid arteries
by: Diliara M. Sharifullina, et al.
Published: (2022-01-01)

Bilateral triceps surae muscle focal myositis after a cauda equina syndrome
by: G.R. González Toledo, et al.
Published: (2021-10-01)

Miositis focal de tríceps sural bilateral post-síndrome de cola de caballo
by: G.R. González Toledo, et al.
Published: (2021-10-01)

Perfil antiinflamatorio del paricalcitol en el receptor de trasplante renal
by: Javier Donate-Correa, et al.
Published: (2017-11-01)

Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque
by: Paula González-López, et al.
Published: (2022-09-01)

Klotho protects against chronic kidney disease-associated atherosclerotic plaque vulnerability in
by: BI Xianjin, et al.
Published: (2020-03-01)

Association of serum klotho levels with different-staged vascular calcification status in patients with maintenance hemodialysis
by: Yan Lin, et al.
Published: (2022-11-01)

Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
by: Beatriz Martín-Carro, et al.
Published: (2023-03-01)

Klotho Levels and Their Relationship with Inflammation and Survival among Alcoholic Patients
by: Candelaria Martín-González, et al.
Published: (2022-08-01)

Prevalence of combined atherosclerotic vascular lesions in patients with diabetes mellitus
by: Svetlana Alexandrovna Gracheva, et al.
Published: (2012-03-01)

The possibility of early detection of atherosclerotic vascular lesions in rheumatic diseases
by: A. N. Bazhenov, et al.
Published: (2013-06-01)

Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender
by: Pereira Thiago MC, et al.
Published: (2010-08-01)

Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes
by: Ronald B. Goldberg
Published: (2020-10-01)

Immune Checkpoint Inhibitors and Atherosclerotic Vascular Events in Cancer Patients
by: Alessandro Inno, et al.
Published: (2021-05-01)

Trimethylamine N-oxide—a marker for atherosclerotic vascular disease
by: Guinan Xie, et al.
Published: (2021-09-01)

The Role of Perivascular Adipose Tissue in Non-atherosclerotic Vascular Disease
by: Tetsuo Horimatsu, et al.
Published: (2017-11-01)

Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
by: Javier Donate-Correa, et al.
Published: (2021-01-01)

Post-COVID-19 Syndrome (PC19S): Chronic Reactive Endotheliitis and Disseminated Vascular Disease
by: José López Castro
Published: (2020-12-01)

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease
by: Sammons, E, et al.
Published: (2021)

Efficacy of Biologically Active Food Supplements for People with Atherosclerotic Vascular Changes
by: Natalia Pleshkova, et al.
Published: (2022-07-01)

Novel Biomarkers of Atherosclerotic Vascular Disease—Latest Insights in the Research Field
by: Cristina Andreea Adam, et al.
Published: (2022-04-01)

Diffuse Dermal Angiomatosis: A Clue to the Diagnosis of Atherosclerotic Vascular Disease
by: Tueboon Sriphojanart, et al.
Published: (2015-05-01)

Gender Differences in Atherosclerotic Vascular Disease: From Lipids to Clinical Outcomes
by: Tamar Vakhtangadze, et al.
Published: (2021-06-01)

Vascular Dysfunction in Short-Term Hypercholesterolemia despite the Absence of Atherosclerotic Lesions
by: Alireza Garjani, et al.
Published: (2011-08-01)